Acura Pharmaceuticals

Acura Pharmaceuticals is a company listed under the stock ticker ACUR (US).

View the org chart displaying its 11 main executives

Most searched biographies at Acura Pharmaceuticals

• Robert Jones, President, Chief Executive Officer and Director
• George Ross, Director
• Immanuel Thangaraj, Director

Create your alert
to follow the executive moves at Acura Pharmaceuticals.

Acura Pharmaceuticals has 1,837 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Sanofi (France).

Popular M&A news in Pharmaceuticals

• Molex has announced the acquisition of Vectura Group  (posted on September 23 2024).
• Agilent Technologies has acquired BioVectra (posted on September 23 2024).
• OXB will change its company name to OXB on Sep 18, 2024. (posted on September 18 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Robert Langer - Board Member at Moderna
• Paul Meister - Chairman of the Board at Amneal Pharmaceuticals

Learn more about the Pharmaceuticals industry >

Press releases by Acura Pharmaceuticals

• LinkedIn Login, Sign in | LinkedIn
• https://twitter.com/intent/tweet?status=Acura%20Pharmaceuticals,%20Inc.%20-%20Press%20Releases+http%3A%2F%2Finvestors.acurapharm.com%2Fpress-releases
• RSS News Feeds | Acura Pharmaceuticals, Inc.
• Acura Pharmaceuticals Announces Second Quarter 2020 Financial Results | Acura Pharmaceuticals, Inc.
• Acura Pharmaceuticals Announces First Quarter 2020 Financial Results | Acura Pharmaceuticals, Inc.
• Acura Pharmaceuticals Announces Fourth Quarter and Full Year 2019 Financial Results | Acura Pharmaceuticals, Inc.
• Acura Pharmaceuticals Provides an Update on the Development of LTX-03 | Acura Pharmaceuticals, Inc.
• Acura Pharmaceuticals Announces Third Quarter 2019 Financial Results | Acura Pharmaceuticals, Inc.
• Acura Pharmaceuticals Announces Second Quarter 2019 Financial Results | Acura Pharmaceuticals, Inc.
• Acura Pharmaceuticals Provides an Update on the Development of LTX-03 | Acura Pharmaceuticals, Inc.
• View more press releases Close

Social media about Acura Pharmaceuticals

• Acura Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Acura Pharmaceuticals on LinkedIn, Twitter & YouTube

Contact by email its executives including Peter Clemens

Call Acura Pharmaceuticals at +1 847...

View the org chart

Register to receive your alert

Report an error